PCM
ARA

Penn Capital Management’s American Renal Associates Holdings, Inc ARA Stock Holding History

Penn Capital Management’s Portfolio ARA Stock Details ARA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-164,006
Closed -$3.49M – 305
2016
Q4 		$3.49M Sell
164,006
-1,499
-0.9% -$30.8K 0.22% 138
2016
Q3 		$3.02M Buy
165,505
+84,525
+104% +$1.91M 0.21% 140
2016
Q2 		$2.35M Buy
+80,980
New +$2.25M 0.13% 165

Other funds holding ARA

CP
Centerbridge Partners New York $38.1M AUM 9.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AAM
AMI Asset Management Los Angeles, California $1.74B AUM 26.89% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Penn Capital Management's ARA Position: Q1 2017 in Review

Penn Capital Management sold out of American Renal Associates Holdings, Inc (ARA) in Q1 2017, closing a stake of 164,006 shares — an estimated $3.49M sold.

Penn Capital Management first reported a position in ARA in Q2 2016 and held it in 3 quarters. The position peaked at $3.49M in Q4 2016. 59 funds tracked by Wall St. Rank hold ARA as of Q1 2017.

  • Penn Capital Management reported no remaining American Renal Associates Holdings, Inc position as of Q1 2017 after selling out during the quarter.
  • Penn Capital Management sold 164,006 American Renal Associates Holdings, Inc shares in Q1 2017, an estimated $3.49M.
  • Penn Capital Management first reported a position in American Renal Associates Holdings, Inc in Q2 2016 and held it in 3 quarters.
  • Penn Capital Management's American Renal Associates Holdings, Inc position peaked at $3.49M in Q4 2016.
  • 59 funds tracked by Wall St. Rank held American Renal Associates Holdings, Inc as of Q1 2017.

Based on Penn Capital Management's 13F filing for Q1 2017, filed 15 May 2017.